Corrections

BMJ Updates: Yearly infusion of zoledronic acid helps prevent fractures in postmenopausal women with osteoporosis

BMJ 2007; 335 doi: http://dx.doi.org/10.1136/bmj.39316.627014.AD (Published 30 August 2007) Cite this as: BMJ 2007;335:0-a

In this filler item (BMJ 2007;335:36, 7 Jul, doi: 10.1136/bmj.39234.488356.DE), we wrongly reported the frequency of serious atrial fibrillation in the zoledronic acid and placebo groups as “5% v 1.3%, P<0.001”. The correct figures (1.3% v 0.5%, P<0.001) reflect a much lower frequency.

View Abstract